You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BI 754091 (Ezabenlimab)

Showing 1 - 25 of 1,399
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)

Recruiting
  • Neoplasms
  • BI 907828
  • +2 more
  • Santa Monica, California
  • +16 more
Jan 23, 2023

Tumors Trial in Spain, United Kingdom, United States (BI 1387446, BI 754091)

Active, not recruiting
  • Neoplasms
  • BI 1387446
  • BI 754091
  • Chapel Hill, North Carolina
  • +7 more
Jan 23, 2023

Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)

Not yet recruiting
  • Gastrointestinal Cancer
  • +5 more
  • (no location specified)
Oct 16, 2023

Tumor Metastasis Trial in Canada, United Kingdom, United States (BI 754091, BI 754111, BI 836880)

Active, not recruiting
  • Neoplasm Metastasis
  • BI 754091
  • +2 more
  • La Jolla, California
  • +16 more
Jan 9, 2023

Solid Tumors Trial (BI 1703880, Ezabenlimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Aug 8, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • BI 765063
  • +4 more
  • Saint Louis, Missouri
  • +15 more
Aug 10, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • New York, New York
    NYU Langone Health
May 4, 2023

Colorectal Tumors, NSCLC, Pancreatic Tumors, Carcinoma, Hepatocellular, Head and Neck Tumors, Gastrointestinal Tumors Trial in

Recruiting
  • Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
  • Denver, Colorado
  • +4 more
Jan 9, 2023

Tumors Trial in Worldwide (BI 765179, Ezabenlimab)

Recruiting
  • Neoplasms
  • Tucson, Arizona
  • +6 more
Aug 23, 2022

Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Scottsdale, Arizona
  • +10 more
Aug 15, 2022

NSCLC, Head and Neck Tumors Trial in Amsterdam (BI 754111, [89Zr]Zr-BI 754111, BI 754091)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Head and Neck Neoplasms
  • BI 754111
  • +2 more
  • Amsterdam, Netherlands
    Amsterdam UMC Locatie VUMC
Nov 3, 2021

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • (no location specified)
May 25, 2023

Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, NSCLC (NSCLC) Trial in Amsterdam (BI 765063, Ezabenlimab, [89Zr]Zr-

Recruiting
  • Carcinoma, Squamous Cell of Head and Neck (HNSCC)
  • +2 more
  • BI 765063
  • +4 more
  • Amsterdam, Netherlands
    Amsterdam UMC Locatie VUMC
Jan 9, 2023

Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • New York, New York
    Mount Sinai School of Medicine
Jan 10, 2023

Tumors Trial in Japan, Korea, Republic of, Taiwan (BI 754091, BI 754111)

Active, not recruiting
  • Neoplasms
  • BI 754091
  • BI 754111
  • Chiba, Kashiwa, Japan
  • +12 more
Aug 9, 2022

Solid Tumors Trial in Santa Monica, Winston-Salem (BI 1831169, ezabenlimab)

Recruiting
  • Solid Tumors
  • Santa Monica, California
  • +1 more
Aug 23, 2022

Solid Tumors Trial in Canada, Japan, United States (BI 770371, ezabenlimab)

Recruiting
  • Solid Tumors
  • Sarasota, Florida
  • +4 more
Jan 10, 2023

Solid Tumors Trial in Japan (BI 765063, BI 754091)

Completed
  • Solid Tumors
  • BI 765063
  • BI 754091
  • Chiba, Kashiwa, Japan
  • +3 more
May 9, 2022

Tumors Trial in Canada, United Kingdom, United States (BI 754091)

Active, not recruiting
  • Neoplasms
  • BI 754091
  • Sarasota, Florida
  • +12 more
Jan 9, 2023

Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

Active, not recruiting
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • BI 754111
  • BI 754091
  • Miami, Florida
  • +14 more
Jan 9, 2023

Anal Canal Squamous Cell Carcinoma Trial in Seoul (BI 754091, BI 836880)

Withdrawn
  • Anal Canal Squamous Cell Carcinoma
  • BI 754091
  • BI 836880
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 12, 2021

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Solid Tumor, Adult Trial in Belgium, France (BI 765063, BI 754091)

Recruiting
  • Solid Tumor, Adult
  • BI 765063
  • BI 754091
  • Brussels, Belgium
  • +6 more
Dec 20, 2021

Tumors, Tumor Metastasis, NSCLC Trial in Sarasota, Nashville, Milwaukee (BI 891065, BI 754091)

Terminated
  • Neoplasms
  • +2 more
  • BI 891065
  • BI 754091
  • Sarasota, Florida
  • +2 more
Oct 7, 2021

Esophageal Squamous Cell Carcinoma (ESCC) Trial in Taiwan (BI-754091 plus afatinib)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • BI-754091 plus afatinib
  • Kaohsiung, Taiwan
  • +4 more
Aug 30, 2021